Herbert "Skip" Virgin will lead work on translatability of scientific discoveries and translation to new medicines in collaboration with the three Institutes of Science at Altos
SAN FRANCISCO, July 14, 2022 /PRNewswire/ -- Altos Labs (Altos) today announced that Herbert "Skip" Virgin, MD, PhD, will join the company as Chief Medical Officer and Head of the Altos Institute of Medicine, effective September 1, 2022. In his role, Dr. Virgin will lead work on the translatability of scientific discoveries and the translation to transformative medicines in collaboration with the company's three Institutes of Science with the aim to restore cell health and reverse disease. "Skip is a devoted, innovative scientist with an exceptional background in translational medicine, making him an ideal fit for Altos as we seek to reverse disease, injury, and disabilities using new approaches," said Altos Chief Scientist and Founder Rick Klausner. "As we unravel the deep biology of cellular rejuvenation programming, we also need to develop the means of translating that new understanding into medicines. We are honored that Skip has agreed to take on this challenge by leading the Altos Institute of Medicine." "Altos is home to some of the most accomplished scientists in the fields of cell health and cellular rejuvenation programming, and I am excited by the opportunity to lead the Institute of Medicine to help translate this knowledge into transformative medicines," said Dr. Virgin. "Over my career, I've repeatedly encountered one of science's great mysteries: how and why different individuals facing the same disease experience widely variable severity and recovery. Understanding this process at the cellular level – and realizing the potential of that understanding to benefit humanity – is one of many reasons I decided to join Altos to support its efforts to harness cellular resilience." Altos Labs is a new life sciences company focused on restoring cell health and resilience through cellular rejuvenation programming to reverse disease, injury, and the disabilities that occur throughout life. The company comprises a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission. Altos has operations in the San Francisco Bay Area, San Diego, and in Cambridge, UK, with significant collaborations in Japan. To learn more visit www.altoslabs.com and follow us on Twitter or LinkedIn.